Cell death in the nervous system

Advances in Experimental Medicine and Biology

Volumn 557, Issue , 2005, Pages 1-10

  Krieglstein, Kerstin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE; DEATH RECEPTOR; DEATH RECEPTOR 3; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PROTEIN P75; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; CELL DEATH; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; GLIA CELL; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AGING; ANIMALS; APOPTOSIS; CASPASES; CELL DEATH; NERVOUS SYSTEM; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS;

EID: 33744533276     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (111)

1. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991; 14:453-501.
2. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96:245-254.
3. Horvitz HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res 1999; 59:1701s-1706s.
4. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basis biological phenomen with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
5. Häcker G. The morphology of apoptosis Cell Tiss Res 2000; 301:5-17.
6. Shi Y. Mechanisms of caspases activation and inhibition during apoptotsis. Mol Cell 2002; 9:459-470.
7. Majino G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146:3-15.
8. Ellis RE, Yuan JY, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991; 7:663-698.
9. Levi-Montalcini, R. The nerve growth factor 35 years later. Science 1987; 237:1154-1162.
10. Thoenen H, Bandtlow C, Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol 1987; 109:145-178.
11. Landmesser L, Pilar G. Interactions between neurons and their targets during in vivo synaptogenesis. Fed Proc 1987; 37:2016-2022.
12. Landmesser L. The relationship of intermuscular nerve branching and synaptogenesis to motoneuron survival. J Neurobiol 1992; 23:1131-1139.
13. Sohal GS. The role of target size in neuronal survival. J Neurobiol 1992; 23:1124-1130.
14. Hollyday M, Hamburger V. Reduction of the naturally occurring motor neuron loss by enlargement of the periphery. J Comp Neurol 1976; 170:311-320.
15. Pettmann B, Henderson CE. Neuron cell death. Neuron 1998; 20:633-647.
16. De la Rosa EJ, de Pablo F. Cell death in early neural development: beyond the neurotrophic theory. TINS 2000; 23:454-457.
17. Ranger AM, Malynn BA, Korsmeyer SJ. Mouse models of cell death. Nature Genetics 2001; 28:113-118.
18. Kuida K, Zheng TS, Na TQ et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384:368-372.
19. Kuida K, Haydar TF, Kuan CY et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94:325-337.
20. Cecconi F, Gruss P. Apaf1 in developmental apoptosis and cancer: how many ways to die. CMLS 2001; 58:1688-1697.
21. Glückmann A. Cell death in normal vertebrate ontogeny. Biol Rev 1951; 26:59-86.
22. Jacobson MD, Weil M, Raff M. Programmed cell death in animal development. Cell 1997; 88:347-54.
23. Barres BA, Hart IK, Coles HS et al. Cell death and control of survival in the oligodendrocyte lineage. Cell 1992; 70:31-46.
24. Grinspan JB, Marchionni MA, Reeves M et al. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 1996; 16:6107-6118.
25. Trachtenberg JT, Thompson WJ. Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature 1996; 379:174-177.
26. Gu C, Casaccia-Bonnefil P, Srinivasan A et al. Oligodendrocyte apoptotsis mediated by caspases activation. J Neurosci 1999; 19:3043-3049.
27. Winseck AK, Caldero J, Ciutat D et al. In Vivo analysis of Schwann cell programmed cell death in the embryonic chick: regulation by axons and glial growth factor. J Neurosci 2002; 22:4509-4521.
28. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17:2941-1953.
29. Sulston JE, Schierenberg E, White JG et al. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol 1983; 100:64-119.
30. Metzstein MM, Stanfield GM, Horvitz HR. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet 1998; 14:410-416.
31. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281:1312-1316.
32. Nicholson DW, Thornberry NA. Caspases-killer proteases. Trends Biochem. Sci. 1997; 22:299-306.
33. Hofmann K, Bucher P, Tschopp J. The CARD domain-a new apoptotic signaling motif. Trends Biochem Sci 1997; 22:155-156.
34. Chou JJ, Matsuo H, Duan H, Wagner R. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 1998; 94:171-180.
35. Adams JM, Cory S. The bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322-1326.
36. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13:1899-1911.
37. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivowith a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74:609-619.
38. Nguyen M, Millar DG, Yong VW et al. Targeting of Bcl-2 to mitochondrial outer membrane by COOH-terminal signal sequence. J Biol Chem 1993; 268:25265-25268.
39. Hockenberry D, Nunez G, Milliman C et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348:334-336.
40. Hsu YT, Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bel-XL during apoptosis. Proc Natl Acad Sci USA 1997; 94:3668-3672.
41. Gross A, Jockel J, Wei MC et al. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998; 17:3878-3885.
42. Liu X, Kim CN, Yang J et al. Induction of apoptotic program in cell-free extreacts: requirement for dATP and cytochrome c. Cell 1996; 86:147-157.
43. Kluck RM, Bossy-Wetzel E, Green DR et al. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275:1132-1136.
44. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspases activation and independently of mitochondrial trans-membrane depolarization. EMBO J 1998; 17:37-49.
45. Li P, Nijhawan D, Budihardjo I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspases-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479-489.
46. Zou H, Henzel WJ, Liu X et al. Apaf-1, a human homolog to C. elegans CED-4 participates in cyrochrome c-dependent activation of caspases-3. Cell 1997; 90:405-413.
47. Sanna MG, da Silva Correia J, Ducrey O et al. IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 siganling cascade and caspases inhibition. Mol Cell Biol 2002; 22:1754-1766.
48. Roy N, Mahadevan MS, McLean M et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995; 80:167-178.
49. Shin S, Sung BJ, Cho YS et al. An apoptotic protein human surviving is a direct inhibitor of caspases-3 and caspases-7. Biochemistry 2001; 40:1117-1123.
50. Tamm I, Wang Y, Sausville DA et al. IAP-family protein surviving inhibits caspases activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58:5315-5320.
51. Wienseck AK, Caldero J, Ciutat D et al. In vivo analysis of Schwann cell programmed cell death in the embryonic chick: regulation by axons and glial growth factor. J Neurosci 2002; 22:4509-4521.
52. McCarthy NJ, Whyte MK, Gilbert CS, et al. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol 1997; 136:215-227.
53. Joza N, Susin SA, Daugas E et al. Essential role of mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001; 410:549-554.
54. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281:1305-1308.
55. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76:959-962.
56. Gruss HJ, Dower SK. Tumor necrosis factor logand superfamily: invovlvement in the pathology of malignant lymphomas. Blood 1995; 85:3378-3404.
57. Tartaglia LA, Ayres TM, Wong GH et al. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74:845-853.
58. Nagata S. Apoptosis by death factor. Cell 1997; 88:355-365.
59. Huang B, Eberstadt M, Olejniczak ET et al. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 1996; 384:638-641.
60. Boldin MP, Goncharov TM, Goltsev YV et al. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996; 85:803-815.
61. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85:817-827.
62. Muzio M, Stockwell BR, Stennicke HR et al. An induced proximity model for caspases-8 activation. J Biol Chem 1998; 273:2926-2930.
63. Liepinsh E, Hag LI, Otting G et al. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J 1997; 16:4999-5005.
64. Frade JM, Rodriguez-Tebar A, Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996; 383:166-168.
65. Naumann T, Casademunt E, Hollerbach E et al. Complete deletion of the neurtrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J Neurosci 2002; 22:2409-2418.
66. Miller FD, Kaplan DR. Neurotrophin signaling pathways regulating neuronal apoptosis. CMLS 2001; 58:1045-1053.
67. Chao MV, Bothwell M. Neurotrophins: to cleave or not to cleave. Neuron 2002; 33:9-12.
68. Casademunt E, Carter BD, Benzel I et al. The zinc finger protein NRIF interacts with the neurotrophin receptor p75NTR and participates in programmed cell death. EMBO J 1999; 21:6050-6061.
69. Frade JM, Barde YA. Genetic evidence for cell deathmediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 1999; 126:683-690.
70. Furuta Y, Piston DW, Hogan BL. Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development 1997; 124:2203-2212.
71. Graham A, Koentges G, Lumsden A. Neural crest apoptosis and the establishment of craniofacial pattern: an honorable death. Mol Cell Neurosci 1996; 8:76-83.
72. Krieglstein K, Richter S, Farkas L et al. Reduction of endogenous transforming growth factor beta prevents ontogenetic neuron death. Nature Neuroscience 2000; 3:1085-1091.
73. Dünker N, Schuster N, Krieglstein K. Transforming Growth Factor Beta Modulates Programmed Cell Death in the Retina of the Developing Chick Embryo. Development 2001; 128:1933-1942.
74. Parkinson DB, Dong Z, Bunting H et al. Transforming growth factor β(TGF-β) mediates Schwann cell death in vitro and in vivo: examination of c-jun activation, interactions with survival signals, and the relationship of TGF-β-mediated death to Schwann cell differentiation. J Neurosci 2001; 21:8572-8585.
75. Yu C, Takeda M, Soliven B. Regulation of cell cycle proteins by TNF-alpha and TGF-beta in cells of oligodendroglial lineage. J Neuroimmunol 2000; 108:2-10.
76. Schuster N, Bender H, Philippi A et al. TGF-β induces cell death in the oligodendroglial cell line OLI-neu. Glia 2002; 40:95-108.
77. Schuster N, Bender H, Roessler O et al. TGF-β and TNF-α cooperate to induce apoptosis in the oligodendroglial cell line OLI-neu. J Neurosci Res 2003; 73(3):324-33.
78. Hagimoto N, Kuwano K, Inoshima I et al. TGF-β1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 2002; 168:6470-6478.
79. Schuster N, Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 2002; 307:1-14.
80. Honig LS, Rosenberg RN. Apoptosis and neurologic disease. Am J Med 2000; 108:317-330.
81. Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tiss Res 2000; 301:173-187.
82. Springer JE, Nottingham SE, McEwen ML et al. Caspase-3 apoptotic signaling following injury to the central nervous system. Clin Chem Lab Med 2001; 39:299-307.
83. Dikranian K, Ishimaru MJ, Tenkova T et al. Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis 2001; 8:359-379.
84. Jellinger KA. Cell death mechanisms in neurodegeneration. J Cell Mol Med 2001; 5:1-17.
85. Schulz JB, Weller M, Moskowitz MA. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 1999; 45:421-429.
86. Kugler S, Straten G, Kreppel F. The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ 2000; 7:815-824.
87. Pender MP, Rist MJ. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 2001; 36:137-144.
88. Zipp F, Krammer PH, Weller M. Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system. Immunol Today 1999; 20:550-554.
89. Higami Y, Shimokawa I. Apoptosis in the aging process. Cell Tiss Res 2000; 301:125-132.
90. Motoyama N, Wang F, Roth KA et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995; 267:1506-1510.
91. Knudson CM, Tung KS, Tourtellotte WG et al. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995; 270:96-99.
92. Lindsten T, Ross Aj, King A et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 2000; 6:1389-1399.
93. Cecconi F, Alvarezboaldo G, Meyer BI et al. Apafl (Ced-4 homolog) regulates programmed cell death in mammalian development. Cell 1998; 94:727-737.
94. Yoshida H, Kong YY, Yoshida R et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998; 94:739-750.
95. Honarpour N, Du C, Richardson JA et al. Adult Apaf-1-deficient mice exhibit male infertility. Dev Biol 2000; 218:248-258.
96. Hakem R, Hakem A, Duncan GS et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998; 94:339-352.
97. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17:3261-3270.
98. Brojatsch J, Naughton J, Rolls MM. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leucosis-sarcoma viruses and mediates apoptosis. Cell 1996; 87:845-855.
99. Chinnaiyan AM, O'Rourke K, Yu GL et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996; 274:990-992.
100. Kitson J, Raven T, Jiang YP et al. A death-domain-containing receptor that mediates apoptosis. Nature 1996; 384:371-375.
101. Chicheportiche Y, Bourdon PR, Xu H et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997; 272:32401-32410.
102. Marsters SA, Sheridan JP, Pitti RM et al. Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol 1998; 8:525-528.
103. Pan G, Ni J, Wei YF et al. An antagonist decoy receptor and a death domain-containg receptor for TRAIL. Science 1997; 277:815-818.
104. Wiley SR, Schooley K, Smolak PJ et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3:673-682.
105. Pitti RM, Marsters SA, Ruppert S et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271:12687-12690.
106. Marsters SA, Pitti RM, Donahue CJ et al. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol 1996; 6:750-752.
107. Pan G, O'Rourke K, Chinnaiyan AM. The receptor for the cytotoxic ligand TRAIL. Science 1997; 276:111-113.
108. Sheridan JP, Marsters SA, Pitti RM et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997; 277:818-821.
109. Walczak H, Degli-Esposti MA, Johnson RS et al. TRAIL-Ra: a novel apoptosis-mediating receptor for TRAIL. EMBO J 1997; 16:5386-5397.
110. Wu GS, Burns TF, McDonald ER III et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 1997; 17:141-143.
111. Chaudhary PM, Eby M, Jasmin A et al. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Innumity 1997; 7:821-830.